Sixth Street, KKR to Provide BridgeBio $1 Billion in Preferred Equity
2026-07-01 01:55:21
Sixth Street Partners and KKR & Co. have agreed to provide $1 billion of preferred equity to biotechnology company BridgeBio Pharma Inc., according to Bloomberg, citing people with knowledge of the matter.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
